Gentian was started by brothers Erling and Bård Sundrehagen in 2001. Having originally worked together during the founding of Axis (later Axis-Shield ltd, Alere inc. and now Abbott), they were eager to start a new, innovative venture together in the diagnostics field. From a small office in central Moss, 50 km south of Oslo, Norway, speaking to laboratory doctors across Scandinavia, they quickly identified a gap in the IVD market for a high quality, sensitive, turbidimetric cystatin C immunoassay.
The Gentian Cystatin C Immunoassay was launched in 2006 and after fast uptake in Sweden, an FDA 510k clearance was achieved in 2008. The Beijing representative office was opened in 2010 and Gentian USA Inc.established 2012 to expand the global reach of Gentian. Gentian’s multi-platform assay was adapted for use on instruments in centralized laboratories worldwide and OEM partners were established.
The company soon outgrew the their original facilities and opened up a dedicated laboratory and office space in 2011 in Moss, which was further expanded in 2016. The team expanded and development began on multiple new products.
On 14th December, 2016, Gentian Diagnostics AS was admitted to the Oslo Stock Exchange list ‘Merkur Market’.